Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS ELIZABETH

  • FDA Approval
  • June 27, 2023, 11:40 UTC
  • 28
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • June 27, 2023, 11:40 UTC
  • 27
  • 0 comments

FDA approve POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • June 27, 2023, 11:40 UTC
  • 27
  • 0 comments

FDA approve IBANDRONATE SODIUM

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • June 27, 2023, 11:40 UTC
  • 25
  • 0 comments

FDA approve KETAMINE HYDROCHLORIDE

Comment Full text

PFIZER INC

  • FDA Approval
  • June 26, 2023, 17:31 UTC
  • 30
  • 0 comments

FDA approve RITLECITINIB

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • June 26, 2023, 11:37 UTC
  • 24
  • 0 comments

FDA approve AMPHETAMINE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • June 26, 2023, 11:37 UTC
  • 24
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

RUBICON

  • FDA Approval
  • June 26, 2023, 11:37 UTC
  • 30
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • June 26, 2023, 11:37 UTC
  • 26
  • 0 comments

FDA approve LEVOBUNOLOL HYDROCHLORIDE

Comment Full text

RHODES PHARMS

  • FDA Approval
  • June 26, 2023, 11:37 UTC
  • 25
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 771
  • 772
  • 773
  • 774
  • 775
  • Next

Search

News categories

  • Technical Exchange News(12075)
  • Event(5344)
  • SEC News(251190)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150412)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin